Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Cagrilintide for Sale > CGL10 High-quality peptides,white powder//provide home delivery service-available in stock in the warehouse 11
CGL10 High-quality peptides,white powder//provide home delivery service-available in stock in the warehouse 11 buy - large image1
CGL10 High-quality peptides,white powder//provide home delivery service-available in stock in the warehouse 11 buy - image1
CGL10 High-quality peptides,white powder//provide home delivery service-available in stock in the warehouse 11 buy - image2
CGL10 High-quality peptides,white powder//provide home delivery service-available in stock in the warehouse 11 buy - image3
CGL10 High-quality peptides,white powder//provide home delivery service-available in stock in the warehouse 11 buy - image4
CGL10 High-quality peptides,white powder//provide home delivery service-available in stock in the warehouse 11 buy - image5
CGL10 High-quality peptides,white powder//provide home delivery service-available in stock in the warehouse 11 buy - image6

CGL10 High-quality peptides,white powder//provide home delivery service-available in stock in the warehouse 11

TDS 63 Inquiries

Unit Price:

$50/BOU FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Research Grade

Content:

99%

Port:

深圳

Brand:

Generic

Packaging:

10mg/Vial

Price valid (until):

2026-10-16

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Average Lead Time:
1 days
Qualification:
Main Products:

Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name:Elare

    Whatsapp:+852 5535 7215

    Please add me for our latest price list and COA


      Product Detail  





    1. CGL10 10mg Product Details

      Product Overview

      Product Name: CGL10
      Specification: 10 mg
      Product Code: CGL10
      Packaging: Subject to the actual product packaging and verified supplier documentation
      Product Form: Subject to the actual product and applicable product documentation

      CGL10 10mg is identified by the product name, product code, and specification stated above. This product description is prepared for accurate product identification and professional purchasing communication.

      All information presented in this listing should correspond to the actual product supplied by the seller. Product identity, specifications, packaging, technical characteristics, quality information, safety information, and regulatory status should be verified against authentic and current documentation before publication or commercial transaction.

      Where a product parameter has not been verified, it should not be presented as a confirmed specification. The supplier should update the listing whenever the actual product information or applicable regulatory requirements change.

      Product Specification

      The stated specification of CGL10 is 10 mg.

      The actual package configuration, quantity, batch information, appearance, physical characteristics, purity, assay, and other quality parameters should be determined according to the applicable product documentation.

      The product code alone should not be used to infer chemical composition, regulatory status, safety classification, intended use, or other characteristics that have not been verified.

      Where batch-specific information is available, the applicable batch documentation should prevail over general marketplace information.

      Customers requiring detailed technical information should request the relevant documentation from the supplier before placing an order.

      Product Identification

      For accurate product identification, the supplier should maintain complete and consistent product information.

      Depending on the actual product, relevant information may include:

      • Product name;
      • Product code;
      • Specification;
      • Manufacturer information;
      • Batch or lot number;
      • Packaging details;
      • Technical specifications;
      • Quality documentation;
      • Safety documentation, where applicable;
      • Regulatory documentation, where applicable.

      If a CAS number is applicable to the actual product, it should only be provided after verification through reliable documentation.

      Molecular formula, molecular weight, purity, assay, composition, hazard classification, transportation classification, and other technical parameters should likewise be published only when supported by appropriate product documentation.

      Unverified information should not be invented, estimated, or copied from another product.

      Quality Information

      The supplier should maintain appropriate quality documentation for CGL10 10mg.

      Depending on the nature of the actual product and applicable requirements, documentation may include a product specification sheet, Certificate of Analysis, batch information, manufacturer documentation, Safety Data Sheet, or other legally permitted supporting documents.

      All quality information should accurately correspond to the actual product and, where applicable, the relevant production batch.

      Documents belonging to another product, another manufacturer, or another batch should not be presented as evidence for CGL10.

      Customers may request appropriate quality documentation before purchase where detailed verification is required.

      Regulatory Compliance

      The publication and transaction of CGL10 10mg are subject to the current ECHEMI platform rules and applicable laws and regulations.

      The regulatory classification of the product should be determined according to its actual identity, composition, properties, intended application, and the jurisdiction in which the product is manufactured, supplied, transported, imported, or used.

      If the actual product falls within a regulated category, including hazardous chemicals, dangerous goods, controlled substances, restricted products, pharmaceutical products, or other specially regulated categories, the supplier must comply with the relevant requirements before publication or transaction, as applicable.

      Where a specific license, permit, registration, supplier qualification, authorization, or other supporting documentation is required, the supplier should obtain and maintain the relevant documentation.

      The product should only be published and supplied within the permitted scope of the supplier's qualifications.

      ECHEMI Compliance Statement

      The supplier should submit truthful, accurate, and complete information for ECHEMI review.

      The supplier should not attempt to bypass platform review by changing the actual product name, entering an unrelated CAS number, splitting keywords, concealing the actual identity of the product, incorrectly changing the product category, or making unsupported claims about regulatory status.

      The product title, description, specification, images, documentation, packaging information, and actual goods should remain consistent.

      If ECHEMI requests qualification documents or additional supporting materials, the supplier should provide authentic documents through the appropriate platform process.

      This listing does not make an unsupported claim that CGL10 is hazardous or non-hazardous, regulated or non-regulated, restricted or unrestricted.

      The actual classification should be determined from verified documentation and applicable regulatory requirements.

      Safety Information

      Safety information should be based on the actual product and valid supporting documentation.

      Where a Safety Data Sheet or equivalent safety documentation is applicable, customers should review the relevant information before handling, storing, transporting, or otherwise dealing with the product.

      Specific hazard statements, precautionary statements, hazard classifications, emergency procedures, transportation classifications, or packaging groups should not be stated unless they are supported by appropriate documentation.

      The absence of a particular safety statement in this general description should not be interpreted as confirmation that the product has no safety or regulatory requirements.

      Storage and Handling

      Storage and handling conditions should be determined according to the official documentation applicable to the actual product.

      Customers should follow the instructions provided on the actual product label and relevant technical or safety documentation.

      Specific storage temperatures, humidity requirements, shelf-life information, handling procedures, or other conditions should only be published when supported by reliable product documentation.

      The supplier should ensure that the actual product is packaged, stored, and handled in a manner consistent with applicable requirements.

      Packaging Information

      The final packaging configuration should be confirmed against the actual product.

      Packaging information may include the container type, quantity, labeling, batch identification, product identification, and other applicable markings.

      Product images used on the platform should accurately represent the actual goods.

      Images should not be used to imply a certification, authorization, safety classification, product composition, or regulatory status that cannot be supported by official documentation.

      Where special packaging or labeling requirements apply, the supplier should ensure compliance before shipment.

      Transportation

      Transportation requirements depend on the actual characteristics and regulatory classification of the product.

      Before shipment, the supplier and relevant logistics provider should determine whether any special transportation requirements apply.

      No dangerous-goods classification, transportation category, or exemption should be stated without appropriate supporting documentation.

      If the actual product is subject to regulated transportation requirements, the applicable packaging, labeling, documentation, carrier, and handling procedures should be followed.

      For international transactions, both parties should verify the applicable import, export, customs, transportation, and documentation requirements of the destination market.

      Intended Application

      Any statement regarding the intended application of CGL10 should be based on verified information and applicable documentation.

      This listing does not make unsupported claims concerning medical treatment, therapeutic effects, diagnosis, disease prevention, performance enhancement, or other specialized effects.

      Where a legitimate professional or industrial application is officially documented, it should be described accurately and only within the scope permitted by applicable laws, regulations, and ECHEMI requirements.

      No unsupported claim of approval, authorization, certification, efficacy, or official recognition should be included.

      Documentation and Verification

      Before publication, suppliers should verify the following information:

      Product Name: CGL10
      Specification: 10 mg
      Product Code: CGL10
      CAS Number: To be confirmed from authentic documentation, if applicable
      Molecular Formula: To be confirmed, if applicable
      Molecular Weight: To be confirmed, if applicable
      Purity/Assay: To be confirmed from applicable quality documentation
      Manufacturer: To be confirmed
      Packaging: To be confirmed
      Safety Classification: To be determined from applicable documentation and regulations
      Transportation Classification: To be determined where applicable
      Supplier Qualification: To be confirmed where required

      If any item has not been verified, it should remain unconfirmed rather than being completed with assumptions.

      Customer Responsibilities

      Customers should determine whether purchasing, importing, possessing, storing, handling, transporting, or using the product is permitted under the laws and regulations applicable to their location and intended application.

      Where a permit, registration, import authorization, end-use document, or other qualification is required, the customer should complete the applicable procedures before purchasing or importing the product.

      Customers should review relevant product documentation and safety information before making a purchasing decision.

      Supplier Responsibilities

      The supplier is responsible for ensuring that all product information submitted to ECHEMI is truthful, accurate, complete, and consistent with the actual goods.

      The supplier should ensure that:

      • The product identity is accurate;
      • The stated specification is correct;
      • Technical parameters are supported by documentation;
      • Product images represent the actual goods;
      • Uploaded documents correspond to the listed product;
      • Batch information is accurate where applicable;
      • Required qualifications are valid;
      • Applicable regulatory requirements are satisfied;
      • No misleading or unsupported claims are included.

      Where a particular product category requires qualification documents, the supplier should complete the relevant qualification process before publication or transaction.

      Compliance Disclaimer

      This product description is provided for general product identification and purchasing information purposes only.

      It does not constitute a certification that CGL10 10mg is non-hazardous, non-regulated, unrestricted, approved, authorized, or exempt from any applicable regulatory requirement.

      The actual regulatory status of CGL10 10mg must be determined according to the authentic product identity, official documentation, applicable laws and regulations, and current ECHEMI requirements.

      If the product is subject to hazardous-chemical controls, restricted publication, qualification requirements, or other regulatory controls, the supplier should complete the applicable compliance procedures before publication or transaction.

      Nothing in this description is intended to circumvent ECHEMI review, qualification requirements, or applicable laws and regulations.

      Final Notice

      The supplier should review the complete product information and supporting documentation before submitting CGL10 10mg for platform approval.

      If ECHEMI identifies the product or its description as potentially falling within a regulated category, the supplier should verify the actual product identity and regulatory status rather than attempting to conceal or alter relevant information.

      Where qualification documents are required but have not yet been uploaded or verified, the supplier should complete the applicable documentation process before making claims that depend on such qualifications.

      All product information should be authentic, accurate, current, and consistent with the actual goods.

      In the event of any conflict between this general product description, official product documentation, applicable laws and regulations, or ECHEMI platform requirements, the applicable official requirements and verified documentation shall prevail.



    Items Specifications
    Product Name CGL10
    Grade Research Grade
    Package 10mg/Vial
    Appearance White Lyophilized Powder
    Model CGL10 10mg
    Brand Generic

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 1

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 2
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 3
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 4
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 5
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 6
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 7
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 8
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 9
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 10
    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Certificates
    • CGL10 High-quality peptides,white powder//provide home delivery service-available in stock in the warehouse 11 Certificates 1 TDS

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    ‌Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide

    CAS No.:

    1415456-99-3

    Molecular Formula:

    C194H312N54O59S2

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides

    Location:

    Y17, Room 310, East Third Floor, No. 64 and 66 Jianzhong Road, Tianhe District, Guangzhou City

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1 days

    Total Employees:

    11-50

    Year of Establishment:

    2026

    Founded in 2024, PGpeptides is a specialized supplier of high-purity
    research peptides serving the global scientific community. With deep
    industry expertise, we deliver consistent product quality, competitive
    pricing, and flexible service tailored to research institutions, laboratories,
    and distributors worldwide.
    Our operations span North America, Europe, Asia, Australia, and the
    Middle East, backed by a mature international trade infrastructure and a
    reliable global fulfillment network. We have earned strong recognition 
    and trust across the markets we serve.
  • Inquiry History
    63 Inquiries
    Country Product Purchase Quantity Date Posted
    Australia

    Cagrilintide

    20 MG Aug 17, 2026
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    Australia

    Cagrilintide

    4 MT Mar 9, 2026
    United States

    Cagrilintide

    15 MG Feb 25, 2026
    United States

    Cagrilintide

    10 PCS Dec 27, 2025
    United States

    Cagrilintide

    2 MT Dec 21, 2025
    United States

    Cagrilintide

    100 MG Oct 28, 2025
    United States

    cagrilintide

    2 MT Aug 8, 2025
    Philippines

    Retatrutide

    5 MG Aug 5, 2025
    China

    Cagrilintide

    100 G May 6, 2025
    United States

    cagrilintide

    5 MG Feb 18, 2025
    United States

    Cagrilintide

    3 MT Feb 7, 2025
    United States

    Cagrilintide

    100  Nov 12, 2024
    United States

    Cagrillintide Lyophilized powder

    100 MG Jul 4, 2024
    United States

    Cagrillintide Lyophilized powder

    1000 MG Apr 20, 2024
    Germany

    CAGRILINTIDE

    50 MG Sep 21, 2026
    Australia

    Cagrilintide

    1 G Aug 25, 2026
    United States

    Retatrutid3

    10 MT Aug 4, 2026
    United States

    Retatrutide

    20 MT Jul 25, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.